BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 10166487)

  • 1. Point/counterpoint. The HMO pharmacy benefit. In-house pharmacy administration: the benefits of integration.
    Penna P
    HMO; 1995; 36(4):56, 58-9. PubMed ID: 10166487
    [No Abstract]   [Full Text] [Related]  

  • 2. Point/counterpoint. The HMO pharmacy benefit. Contracted pharmacy services: the value of a carve-out PBM.
    Reissman D
    HMO; 1995; 36(4):57, 60-1. PubMed ID: 10166488
    [No Abstract]   [Full Text] [Related]  

  • 3. Choosing the right PBM.
    Brodsky KL
    HMO; 1995; 36(3):107-9, 112. PubMed ID: 10166470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reimbursement for cognitive pharmacy services.
    Navarro RP
    Manag Care Interface; 1998 Jul; 11(7):57-9. PubMed ID: 10181571
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacy factors that influence the success of integrated health care systems.
    Penna PM
    Am J Health Syst Pharm; 1996 Feb; 53(4 Suppl 1):S7-10. PubMed ID: 8673680
    [No Abstract]   [Full Text] [Related]  

  • 6. Implementation of a pharmacy benefit to a managed Medicaid population.
    Smith WW; Perry SC
    Med Interface; 1995 Dec; 8(12):84-7, 97. PubMed ID: 10153524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data watch. Is this the way to manage pharmacy costs?
    Bus Health; 1997 Sep; 15(9):94. PubMed ID: 10173238
    [No Abstract]   [Full Text] [Related]  

  • 8. New concepts in health benefits. Three-tier drug copays.
    Reese S
    Bus Health; 2000 Apr; 18(4):29-30, 32, 35. PubMed ID: 10915290
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing medication errors.
    Rogers B
    Healthplan; 1997; 38(6):27-31, 34. PubMed ID: 10176883
    [No Abstract]   [Full Text] [Related]  

  • 10. Next HMO quality hurdle: integrating medical and pharmacy data.
    Manag Care; 1996 Aug; 5(8):54. PubMed ID: 10160145
    [No Abstract]   [Full Text] [Related]  

  • 11. Can providers survive when accepting pharmacy risk?
    Capitation Manag Rep; 1999 Mar; 6(3):33-6. PubMed ID: 10351431
    [No Abstract]   [Full Text] [Related]  

  • 12. HMO pharmacy directors' opinions of acquisition of pharmacy benefit management companies.
    Lawrence DB; Weart CW
    Am J Health Syst Pharm; 1995 Jul; 52(14):1547-9. PubMed ID: 7552898
    [No Abstract]   [Full Text] [Related]  

  • 13. Working with PBMs (pharmacy benefit managers).
    Peterson C
    Healthplan; 1999; 40(2):83-6, 88-9. PubMed ID: 10537477
    [No Abstract]   [Full Text] [Related]  

  • 14. Perspectives. Options vs. limits: drug cost strategies reconsidered.
    Cunningham R
    Faulkner Grays Med Health; 1997 Sep; 51(38):suppl 4. PubMed ID: 10173171
    [No Abstract]   [Full Text] [Related]  

  • 15. Compensating the pharmacy services manager.
    Manag Care; 2001 Jul; 10(7):18. PubMed ID: 11494817
    [No Abstract]   [Full Text] [Related]  

  • 16. Getting serious about generics.
    Sipkoff M
    Manag Care; 2003 Jan; 12(1):36-9. PubMed ID: 12575509
    [No Abstract]   [Full Text] [Related]  

  • 17. How the institutional aspects of pharmacy practice operate in an HMO setting.
    Ebel JA
    Pharm Times; 1987 Feb; 53(2):37-8, 43. PubMed ID: 10281072
    [No Abstract]   [Full Text] [Related]  

  • 18. HMOs try formularies in effort to curb prescription costs.
    Feldman A
    Contract Healthc; 1988 Jul; ():33-5. PubMed ID: 10290628
    [No Abstract]   [Full Text] [Related]  

  • 19. The HMO-PBM relationship: getting along in today's market.
    Strein GW
    Med Interface; 1996 Jan; 9(1):70-3. PubMed ID: 10153794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. As drug costs rise, health plans shift the burden.
    Capitation Manag Rep; 1997 Oct; 4(10):153-8. PubMed ID: 10175783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.